Basel Area Business & Innovation has relaunched its DayOne Accelerator, a programme dedicated to international early stage healthtech ventures looking to engage with the pharma industry. The Accelerator is based in Basel, Switzerland – a leading life sciences hub, home to pharma giants like Novartis and Roche. DayOne is equity-free, pharma company-neutral, and designed to […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!